The adolescents training and learning to avoid steroids (ATLAS) prevention program: Background and results of a model intervention

Archives of Pediatrics and Adolescent Medicine

Volumn 150, Issue 7, 1996, Pages 713-721

  Goldberg, Linn ^a   Elliot, Diane L ^a   Clarke, Gregory N ^a   MacKinnon, David P ^b   Zoref, Leslie ^a   Moe, Esther ^a   Green, Christopher ^a   Wolf, Stephanie L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; STEROID;

ADOLESCENCE; ADOLESCENT; ARTICLE; ATHLETE; BODY IMAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; EDUCATION PROGRAM; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SELF REPORT; SOCIAL ENVIRONMENT;

EID: 0029999486     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1996.02170320059010     Document Type: Article

References (46)

1. Bukoski WJ. A framework for drug abuse prevention research. NIDA Res Monogr. 1991;107:7-28.
2. Flay BR. Efficacy and effectiveness of trials (and other phases of research) in the development of health promotion programs. Prev Med. 1986;15:451-474.
3. Buckley WE, Yesalis CE, Friedl KE, Anderson KA, Streit AL, Wright JE, Estimated prevalence of anabolic steroid use among male high school seniors. JAMA. 1988;260:3441-3445.
4. Shephard RJ, Killinger D, Fried T. Responses to sustained use of anabolic steroid. Br J Sports Med. 1977;11:170-173.
5. Mokrohisky ST, Ambruso DR, Hathaway WE. Fulminant hepatic neoplasia after androgen therapy. N Engl J Med. 1977;296:1411-1412.
6. Johnson FL. Hepatoma associated with androgenic steroids. Lancet. 1975;1: 1294-1295.
7. McDonald EC, Speicher CE. Peliosis hepatitis associated with administration of oxymetholone. JAMA. 1978;240:243-244.
8. Frankle MA. Anabolic-androgenic steroids: a guide for the physician. J Musculoskel Med. 1989;6:69-88.
9. Pope HG, Katz DL. Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry. 1988;145:487-490.
10. Webb OL, Laskarzewski PM, Guleck CJ. Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism. 1984;33:971-975.
11. Messerli FH, Frohlich ED. High blood pressure: a side effect of drugs, poisons, and food. Arch Intern Med. 1979;139:682-687.
12. Sklarek HM, Mantovani RP, Erens E, Heisler D, Diederman MS, Gein AM. AIDS in a bodybuilder using anabolic steroids. N Engl J Med. 1984;311:1701.
13. Strauss RH, Wright JE, Finerman GAM, Catlin DH. Side effects of anabolic steroids in weight-trained men. Phys Sports Med. 1983;11(12):87-96.
14. Moore WV. Anabolic steroid use in adolescence. JAMA. 1988;260:3484-3486.
15. Johnson MD, Jay MS, Shoup B, Rickert VI. Anabolic steroid use by male adolescents. Pediatrics. 1989;83:921-924.
16. Goldberg L, Bosworth E, Bents R, Trevisan L. Effect of an anabolic steroid education program on knowledge and attitudes of football players. J Adolesc Health Care. 1990;11:210-214.
17. Cleary B, Folker R, Thompson H, Jarrett G, Goldberg L. Increasing adolescent steroid use: 5 year data. Med Sci Sports Exerc. 1992;24:S45. Abstract.
18. Gilchrist LD. Defining the intervention and the target population. NIDA Res Monogr. 1991;107:13-44.
19. Anderson WA, Albrech RR, McKeag DB, Hough DO, McGrew CA. A national survey of alcohol and drug use by college athletes. Phys Sports Med. 1991; 19:91-104.
20. Carlson H, Cleary B, Carlson N, et al. Ergogenic drugs among high school athletes: trends in knowledge and abuse. Med Sci Sports Exerc. 1991;23:S18. Abstract.
21. Folker R, Ganter B, Cleary B, Carlson H, Elliot D, Goldberg L. Adolescent anabolic steroid users vs. nonusers: differences in knowledge and attitudes. Med Sci Sports Exerc. 1992;24:S44. Abstract.
22. Office of Inspector General. Adolescent Steroid Use. Washington, DC: Dept of Health and Human Services; 1991. Publication OEI-06-90-01080.
23. Bents R, Young J, Bosworth E, Boyea S, Elliot D, Goldberg L. An effective educational program alters attitudes toward anabolic steroid use among adolescent athletes. Med Sci Sports Exerc. 1990;22:S64. Abstract.
24. Jarrett G, Cleary B, Bents R, et al. Beliefs and behaviors of adolescent athletes v. nonathletes: drugs, nutrition and strength training, Med Sci Sports Exerc. 1991;23:S19. Abstract.
25. Jarrett G, Ganter B, Carlson H, et al. Peer delivered anabolic steroid education: adolescent acceptability and outcomes. Med Sci Sports Exerc. 1992;24:S44. Abstract.
26. MacKinnon DP, Johnson CA, Pentz MA, et al. Mediating mechanisms in a school based drug prevention program: first-year effects of the Midwestern Prevention Project. Health Psychol. 1991;10:164-172.
27. Bandura A. Social Learning Theory. Englewood Cliffs, NJ: Prentice Hall; 1977.
28. Fishbein M, Ajzen I. Belief, Attitude, Intention and Behavior. Reading, Mass: Addison-Wesley; 1975.
29. Jessor R, Jessor SL. Problem Behavior and Psychosocial Development. New York, NY: Academic Press; 1977.
30. Fishbein M, Ajzen I, Belief, Attitudes, Intention and Behavior: An Introduction to Theory and Research. Reading, Mass: Addison-Wesley; 1975.
31. Flay BR, Ryan KB, Best JA, et al. Are social-psychological smoking prevention programs effective? The Waterloo study. J Behav Med. 1985;8:37-59.
32. Pentz MA, Trebow E. Implementation issues in drug abuse prevention research. NIDA Res Monogr. 1991;107:123-139.
33. Gaa GL, Griffith EH, Cahill BR, Turtle LD. Prevalence of anabolic steroid use among Illinois high school students. J Ath Training. 1994;29:216-222.
34. Huba GJ, Bentler PM. A developmental theory of drug use: derivation and assessment of a causal modeling approach. In: Baltes BP, Brim OG Jr, eds. Lifespan Development and Behavior. New York, NY: Academic Press; 1982;4:147-203.
35. Smith GM. Perceived effects of substance use: a general theory. In: Theories on Drug Abuse: Selected Contemporary Perspectives. NIDA Res Monogr. 1980; 30:50-58.
36. Thompson H, Cleary B, Folker R, Carlson N, Elliot D, Goldberg L. Adolescent athletes and anabolic steroid abuse: features that characterize the potential user. Med Sci Sports Exerc. 1991;23:S18. Abstract.
37. Hawkins JO, Lishner DM, Catalono RF, Howard MO. Childhood predictors of adolescent substance abuse: toward an empirically grounded theory. In: Griswold-Ezekeye S, Kemfer K, Bukoski W, eds. Children and Clinical Abuse: Prevention ami Intervention. New York, NY: Haworth Press; 1986:11-48.
38. Jacobson GR, Ritter DP, Mueller L. Purpose in life and personal values among adult alcoholics. J Clin Psychol. 1977;33:314-316.
39. Robins LN. Sturdy childhood predictors of adult antisocial behavior: replications from longitudinal studies. Psychol Med. 1978;8:611-622.
40. Goldberg L, Bents R, Bosworth E, Trevisan L. Do scare tactics work? Pediatrics. 1991;87:283-286.
41. Johnston LD, O'Malley PM, Bachman JG. Psychotherapeutic, licit and illicit use of drugs among adolescents. J Adolesc Health Care. 1987;8:36-51.
42. Botvin GJ. Substance abuse prevention research: recent developments and future directions. J School Health. 1986;56:37-59.
43. Ary D, Biglan A, Glasgow R, Zoref L, et al. The efficacy of social influence programs versus 'standard care': are new initiatives needed? J Behav Med. 1990;13:281-296.
44. Klepp KL, Halper A, Perry CL. The efficacy of peer leaders in drug abuse prevention. J School Health. 1986;56:407-411.
45. Botvin HG, Baker E, Filzzola AD, Botvin EM. A cognitive-behavioral approach to substance abuse prevention: one-year follow-up. Addict Behav. 1990;15: 47-63.
46. Dwyer JH, MacKinnon DP, Pentz MA, et al. Estimating intervention effects in longitudinal studies: the Midwestern Prevention Project. Am J Epidemiol. 1989; 130:781-795.